Fibrin encapsulated liposomes as protein delivery system. Studies on the in vitro release behavior.
The efficacy of biologically active proteins in medical therapy depends on the development of suitable drug delivery systems. These delivery systems need to overcome the severe problems connected with the use of proteins such as their usually short half lives in body fluids and their susceptibility to proteolysis and denaturation. Our delivery system combines two widespread devices by encapsulating liposomes containing the model protein horseradish peroxidase (HRP) inside the biopolymer fibrin. The liposomes enable the protein to remain in its preferred aqueous environment and protect it during the polymerization process. Further encapsulation of the liposomes inside fibrin was carried out in order to achieve a depot system with sustained protein release. In vitro experiments showed that the protein filled liposomes were absolutely stable within the fibrin network. In contrast to 'free' HRP, enzyme entrapped in liposomes was completely retained by the fibrin network and wasn't released from the device unless the fibrin was degraded by plasmin.
Meyenburg
S
S
Institut für Biotechnologie, Martin-Luther-Universität Halle-Wittenberg, Kurt-Mothes-Str. 3, 06120 Halle/Saale, Germany.
Lilie
H
H
Panzner
S
S
Rudolph
R
R
D002021:Buffers; D004337:Drug Carriers / Q000737:chemistry*; D004339:Drug Compounding; D005337:Fibrin / Q000737:chemistry*; D015718:Fibrin Tissue Adhesive / Q000737:chemistry; D005614:Freeze Fracturing; D007700:Kinetics; D008081:Liposomes / Q000737:chemistry*; D010316:Particle Size; D011506:Proteins / Q000008:administration & dosage* / Q000737:chemistry
D002021:Buffers; D004337:Drug Carriers; D015718:Fibrin Tissue Adhesive; D008081:Liposomes; D011506:Proteins; D005337:Fibrin